Citi told clients in a recent note that European equity markets have registered one of the steepest rotations toward defensive stocks on record, a pattern usually observed only during episodes of major market stress.
The bank's strategist, Beata Manthey, highlighted that over the last three weeks defensives have risen by about 9% while cyclicals have declined roughly 4%. That divergence was driven by rallies in healthcare and consumer staples that more than offset weakness in sectors such as technology, banks and basic resources.
On a risk-adjusted basis relative to the STOXX 600, the cyclicals-versus-defensives metric has slipped below a -3 standard deviation threshold. According to the note, that extreme reading has only been recorded in 2008, 2020 and 2022.
However, Citi points out a notable distinction from those prior stress episodes: the broader European index remains near its highs. The bank interprets that as evidence the market is experiencing a rotation-driven dynamic rather than broad-based capitulation across equities.
Looking ahead, the bank says the rotation could unwind or pause if risk appetite improves. But the historical pattern cited in the note suggests such pronounced rotations are more likely to be followed by several months of mixed and choppy sector leadership rather than a clean, sustained rebound in cyclicals.
Manthey also notes a valuation and positioning caveat: European cyclicals still trade at a material premium to defensives despite a decelerating earnings outlook and what Citi describes as stretched positioning. That combination underpins the bank's reluctance to advocate for aggressive reallocation into a cyclical recovery at this stage.
Consequently, Citi continues to advocate a barbell portfolio construction. Healthcare is identified as the preferred defensive overweight, paired with targeted cyclical exposure across technology, banks and basic resources.
Summary
- European markets have seen an unusually large rotation from cyclicals into defensives, with defensives up ~9% and cyclicals down ~4% over three weeks.
- The cyclicals-versus-defensives indicator, adjusted to the STOXX 600, has breached a -3 standard deviation level, previously observed only in 2008, 2020 and 2022.
- Citi favors a barbell approach: overweight healthcare as the defensive anchor while keeping selective exposure to tech, banks and basic resources.
Key points
- Defensive sectors - notably healthcare and consumer staples - have significantly outperformed cyclicals in the short term.
- Citi interprets the current pattern as a rotation rather than market-wide capitulation because the STOXX 600 remains near recent highs.
- The bank recommends balancing defensive overweight with selective cyclical holdings rather than pursuing an early, broad cyclical recovery trade.
Risks and uncertainties
- The rotation could reverse or ease if overall risk sentiment improves, affecting sectors that have lagged such as technology, banks and basic resources.
- Extreme rotations historically lead to several months of choppy sector leadership, creating uncertainty for portfolio timing and sector allocation decisions across equities.
- Citi highlights that cyclicals carry a valuation premium to defensives despite slowing earnings expectations and stretched positioning, raising the risk of disappointing returns if earnings underperform.
Conclusion
Citi's analysis frames the recent European sector moves as an acute rotation toward defensive names rather than a market collapse. The bank's recommendation of a healthcare-focused defensive stance, complemented by selective cyclical exposure in tech, banks and basic resources, reflects a cautious response to elevated valuation dispersion and the historical tendency for prolonged, volatile leadership changes after extreme rotations.